Memorial Sloan Kettering Cancer Center: Prostatic Neoplasms trials

The registry lists 129 Prostatic Neoplasms studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 15 are open to participants now and 24 have results posted.

Phase 1 38Phase 2 52Phase 3 8No phase 43(a study in two phases counts in both)

Studies

Page 1 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Radiation Therapy Approaches for People With Prostate CancerRecruitingNCT07751159Phase 2
• A Study of a New PET Scanner in People With CancerRecruitingNCT07690917
• A Study of Lower Dose Radiation Therapy for People With Prostate CancerRecruitingNCT07635238Phase 2
• Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate CancerRecruitingNCT07548164Phase 3
• A Study of Meaning-Centered Therapy for Mexican Adults With Advanced CancerRecruitingNCT07225309Not applicable
• A Study of Tarlatamab for People With Prostate CancerRecruitingNCT07111507Phase 2
• A Study of Changes to Prostate ProceduresRecruitingNCT06986083Phase 3
• MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized TrialRecruitingNCT06954337Not applicable
• A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate CancerRecruitingNCT06457919Phase 1/2
• A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate CancerRecruitingNCT06347705Phase 2
• A Study of Mental Health Care in People With CancerRecruitingNCT06037954Not applicable
• Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer PatientsRecruitingNCT04751435Not applicable
• The Use of Nanoparticles to Guide the Surgical Treatment of Prostate CancerRecruitingNCT04167969Phase 1
• Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer SurgeryRecruitingNCT02706561Not applicable
• [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland CancerRecruitingNCT00588185Not applicable
• Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate CancerActive, not recruitingNCT04262154Phase 2Results posted
• A Study of the Drugs Talazoparib and Temozolomide in Prostate CancerTerminatedNCT04019327Phase 1/2Results posted
• A Study of Olaparib and Durvalumab in Prostate CancerTerminatedNCT03810105Phase 2Results posted
• The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate CancerActive, not recruitingNCT03808077Phase 2Results posted
• Trial of ADT and SBRT Versus SBRT for Intermediate Prostate CancerTerminatedNCT03056638Phase 3Results posted
• AASUR in High Risk Prostate CancerCompletedNCT02772588Phase 2Results posted
• 68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate CancerCompletedNCT02559115Phase 2Results posted
• Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate CancerCompletedNCT02280356Phase 2Results posted
• Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate CancerCompletedNCT02278055Phase 2Results posted
• Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate CancerCompletedNCT02218606Phase 2Results posted
• Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) PatientsCompletedNCT02091531Phase 2Results posted
• Study of 89Zr-DFO-MSTP2109A in Patients With Prostate CancerCompletedNCT01774071Phase 1/2Results posted
• 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical ProstatectomyCompletedNCT01751451Phase 2Results posted
• Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate CancerCompletedNCT01542021Not applicableResults posted
• Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate CancerTerminatedNCT01354951Phase 2Results posted
• Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With CancerTerminatedNCT00773773Not applicableResults posted
• Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and OlderCompletedNCT00741039Phase 2Results posted
• Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain MetastasesCompletedNCT00587964Phase 2Results posted
• Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate CancerCompletedNCT00587431Phase 2Results posted
• Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's CycleCompletedNCT00586898Phase 2Results posted
• Internal Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00573833Not applicableResults posted
• Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate CancerCompletedNCT00142506Phase 3Results posted
• Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate CancerCompletedNCT00085566Phase 1/2Results posted
• PET Scan in Treating Patients With Metastatic Prostate CancerCompletedNCT00002981Not applicableResults posted
• A Study of BMS986365 in Combination With Degarelix in People With Prostate CancerActive, not recruitingNCT07335796Phase 2
• A Study of a Pelvic Floor Muscle Exercise Program Before and After Radical ProstatectomyActive, not recruitingNCT06671782Not applicable
• A Study of Copanlisib in Combination with Degarelix in People with Prostate CancerWithdrawnNCT06218667Phase 1/2
• A Study of Cognitive Health in Survivors of Prostate CancerActive, not recruitingNCT05540782
• An Acupuncture Study for Prostate Cancer Survivors With Urinary IssuesActive, not recruitingNCT05540392Phase 1/2
• A Study of Telemedicine Shared Medical Appointments (SMAs) Versus Individual Telemedicine Visits for People With Prostate CancerActive, not recruitingNCT05416996
• A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate CancerActive, not recruitingNCT05169970Phase 2
• A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the BonesCompletedNCT05133440Phase 2
• A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate CancerActive, not recruitingNCT05100472Phase 2
• A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate CancerActive, not recruitingNCT05079698Phase 1
• A Study of MRI-guided High-dose Radiation Therapy in Prostate CancerActive, not recruitingNCT04997018Phase 2
• Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate CancerActive, not recruitingNCT04030338
• Acupuncture Pilot Study for Cancer-related Cognitive FunctionActive, not recruitingNCT04007770Phase 2
• A Study to Test Radium-223 With Docetaxel in Patients With Prostate CancerActive, not recruitingNCT03574571Phase 3
• Early Staged Consent Before Prostate BiopsyCompletedNCT03507725Not applicable
• Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic AdenocarcinomaActive, not recruitingNCT03436654Phase 2
• AZD5363 in Patients With Advanced Solid Tumors Harboring AKT MutationsCompletedNCT03310541Phase 1
• Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)CompletedNCT03269422Phase 1
• PSMA PET Imaging of Recurrent Prostate CancerActive, not recruitingNCT03204123Phase 2
• Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)CompletedNCT03030885Phase 1
• Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient OutcomesActive, not recruitingNCT02917798
• Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate CancerCompletedNCT02833883Phase 1
• Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission TomographyNo longer availableNCT02531672
• Evaluation of Treatment Response Using Multiparametric MRI After Prostate RadiotherapyActive, not recruitingNCT02312401Phase 2
• [18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate CancerCompletedNCT02297386Phase 1
• ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone AcetateCompletedNCT02106507Phase 1
• Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical RecurrenceCompletedNCT02070575
• A Registry for Patients Treated on the Clinical Trial TAX 3503CompletedNCT01813370
• Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate CancerActive, not recruitingNCT01688492Phase 1/2
• Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate CancerWithdrawnNCT01617174
• Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate CancerCompletedNCT01543659Phase 1/2
• Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate CancersCompletedNCT01535898
• Trial of Modifications to Radical ProstatectomyActive, not recruitingNCT01407263Phase 3
• Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic CancerWithdrawnNCT01163448Phase 1
• Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC)Active, not recruitingNCT01140373Phase 1
• Modifications to Radical Prostatectomy: Feasibility StudyCompletedNCT00928850Not applicable
• Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate CancerCompletedNCT00911118Phase 1
• Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate CancerCompletedNCT00853697Phase 2
• Change in Penile Length Following Bilateral Nerve-Sparing Radical ProstatectomyCompletedNCT00800813
• Study of Focal Cryoablation in Low-Risk Prostate CancerCompletedNCT00774436Phase 2
• Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant AlhydrogelCompletedNCT00705835Phase 1
• Vaccination of Prostate Cancer Patients With MUC-2-KLH Conjugate Plus the Immunological Adjuvant QS21CompletedNCT00698711Phase 1
• Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients.CompletedNCT00695851Phase 1
• Development of a Clinical Trial Specific Question Prompt ListCompletedNCT00662324
• The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate CancerCompletedNCT00605488Not applicable
• High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam RadiotherapyCompletedNCT00604526Phase 1
• Magnetic Resonance Imaging and Spectroscopy of the ProstateCompletedNCT00590993
• Magnetic Resonance Spectroscopic Imaging of the Prostate at 3 TeslaCompletedNCT00588679Not applicable
• Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate CancerCompletedNCT00582842
• MRI/MRSI in Risk Assessment of Prostate Cancer PatientsCompletedNCT00582543Not applicable
• Men Undergoing Radical ProstatectomyCompletedNCT00582530
• Pain in Cancer SurvivorsCompletedNCT00581724
• Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black MenCompletedNCT00581672
• Assessing Depression in a Geriatric Cancer PopulationCompletedNCT00580476
• Germline Alterations of Tumor Susceptibility Genes in New York Cancer PatientsActive, not recruitingNCT00579514Not applicable
• Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate CancerCompletedNCT00579423Phase 2
• Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial CancersActive, not recruitingNCT00579163
• The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and OlderActive, not recruitingNCT00579072
• Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker DataCompletedNCT00578409
• Molecular Studies and Clinical Correlations in Human Prostatic DiseaseActive, not recruitingNCT00578240
• Assessment of the Functional Significance of Accessory Pudendal ArteriesCompletedNCT00577876Not applicable